首页 › 基金 › Catalio Capital Management, LP › MGX
Catalio Capital Management, LP 对 MGX 的持仓历史
METAGENOMI THERAPEUTICS INC · 医疗保健
Catalio Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 MGX(METAGENOMI THERAPEUTICS INC)528,993 股,市值约 US$561K,约占其申报组合的 0.10%,在其申报持仓中市值排名第 43 位。 Catalio Capital Management, LP 最近 8 个申报季度中有 8 个季度披露了 MGX 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Catalio Capital Management, LP 对 MGX 的持仓演变
Catalio Capital Management, LP 于 Q4 2024 首次披露 MGX 持仓:528,993 股(约 US$1.9M)。 在 8 次申报中,Catalio Capital Management, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 528,993 股、市值约 US$561K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 528.99K | $1.91M | 新进 |
| Q1 2025 | 528.99K | $719.43K | 持有 |
| Q2 2025 | 528.99K | $782.91K | 持有 |
| Q3 2025 | 528.99K | $1.25M | 持有 |
| Q4 2025 | 528.99K | $856.97K | 持有 |
| Q1 2026 | 528.99K | $708.85K | 持有 |
| Q2 2026 | 528.99K | $629.50K | 持有 |
| Q3 2026 | 528.99K | $560.73K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MGX 与 13F 数据
MGX(METAGENOMI THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 20 只申报持有 MGX,申报仓位最大的包括:PURA VIDA INVESTMENTS, LLC (US$315K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Catalio Capital Management, LP
常见问题
How long has Catalio Capital Management, LP held MGX?
Catalio Capital Management, LP has disclosed MGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Catalio Capital Management, LP's current position in MGX?
As of Q3 2026, Catalio Capital Management, LP holds 528.99K shares of MGX (METAGENOMI THERAPEUTICS INC), valued at $560.73K, representing 0.10% of its reported portfolio and ranking #43.
Has Catalio Capital Management, LP been buying or selling MGX?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP held unchanged its position in MGX.
Which other funds hold MGX?
Other major institutional holders of MGX include PURA VIDA INVESTMENTS, LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.